Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Lima › NPI 1629144050
Clinic

Lima-Urban Minority Alcoholism and Drug Abuse Outreach Program., INC

Lima-Urban Minority Alcoholism and Drug Abuse Outreach Program., INC was paid $14.79M by Medicaid between Jan 2018 and Dec 2024, across 56 billing codes. Its largest line is H2036, Alcohol and/or other drug treatment program, per diem — 65% of everything it billed.

33Billing provider infoLIMA-URBAN MINORITY ALCOHOLISM AND DRUG ABUSE OUTREACH PROGRAM., INC
LIMA, OH 45801
33aNPI1629144050assigned 11/28/2006
28Total paid$14.79M
24GClaims365,711
24DCodes billed56
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Community Health Clinic/Center providers in Ohio

Rank by total paid#1 of 12
Median peer was paid$155K
This provider vs. median96×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018169,061$4.25M
2019168,542$4.54M
20209,518$1.86M
20217,343$1.79M
20225,102$1.17M
20234,508$1.01M
2024incomplete1,637$168K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
H2036 Alcohol and/or other drug treatment program, per diem 65% 39,215 2,925 $9.67M
H0011 Alcohol and/or drug services; acute detoxification (residential addiction program inpatient) 6.8% 3,092 658 $1.01M
H0006 Alcohol and/or drug services; case management 5.2% 20,617 4,852 $776K
H0015 Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education 4.1% 7,977 1,884 $610K
H0010 Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient) 2.2% 1,768 200 $330K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2.2% 13,469 1,820 $322K
82542 1.4% 10,964 1,350 $202K
T1003 Lpn/lvn services, up to 15 minutes 1.3% 8,727 2,542 $187K
H0048 Alcohol and/or other drug testing: collection and handling only, specimens other than blood <1% 12,510 2,439 $132K
80299 <1% 11,234 1,415 $102K
H0005 Alcohol and/or drug services; group counseling by a clinician <1% 1,214 463 $97K
80346 <1% 9,745 1,272 $96K
44 more codes
80156 <1% 8,818 $77K
80362 <1% 8,945 $57K
90837 Psychotherapy session, about an hour <1% 495 $50K
80354 <1% 8,939 $47K
80348 <1% 8,948 $47K
80349 <1% 9,194 $47K
80345 <1% 8,937 $47K
80361 <1% 8,885 $46K
83516 <1% 4,238 $45K
H0004 Behavioral health counseling and therapy, per 15 minutes <1% 1,908 $42K
80373 <1% 9,043 $41K
80355 <1% 9,050 $41K
80374 <1% 9,031 $41K
80375 <1% 9,039 $41K
T1002 Rn services, up to 15 minutes <1% 1,255 $41K
80357 <1% 9,050 $40K
80370 <1% 9,068 $40K
80368 <1% 9,070 $40K
80372 <1% 9,063 $39K
80366 <1% 8,893 $39K
80367 <1% 8,889 $39K
80359 <1% 8,928 $32K
80360 <1% 8,936 $32K
99213 Doctor's office visit, returning patient (routine) <1% 800 $31K
80356 <1% 8,946 $31K
80371 <1% 8,927 $31K
80320 <1% 3,945 $27K
99214 Doctor's office visit, returning patient (more involved) <1% 272 $26K
80329 <1% 3,098 $17K
80339 <1% 3,048 $14K
H0001 Alcohol and/or drug assessment <1% 442 $10K
80364 <1% 870 $8K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 378 $8K
80333 <1% 2,993 $8K
83992 <1% 914 $7K
80353 <1% 2,435 $6K
80365 <1% 2,390 $5K
80337 <1% 864 $4K
90791 Psychiatric diagnostic evaluation <1% 43 $4K
80325 <1% 324 $2K
80358 <1% 319 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 36 $2K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 3,331 $800.04
80324 <1% 2,182 $530.38

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOYKIN-LIGHTON, MYRTLE (EXECUTIVE DIRECTOR)
Same official

Other billing entities under BOYKIN-LIGHTON, MYRTLE

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.